rapid test; adalimumab; aflibercept; apixaban; bictegravir plus emtricitabine plus tenofovir alafenamide; ibrutinib; lenalidomide; nivolumab; programmed death 1 receptor; rivaroxaban; SARS-CoV-2 vaccine; thalidomide; ubiquitin protein ligase E3; ustekinumab; accounting; apoptosis; editorial; human; malignant neoplasm; pandemic; pill; scientific literature; vaccination; biktarvy; imbruvica; opdivo; stelara